Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

27.34
+0.04000.15%
Post-market: 27.340.00000.00%19:17 EDT
Volume:1.25M
Turnover:34.16M
Market Cap:2.58B
PE:-4.65
High:27.58
Open:27.42
Low:27.00
Close:27.30
Loading ...

Will FDA Response and New Stock Offering Change Ultragenyx Pharmaceutical's (RARE) Narrative?

Simply Wall St.
·
24 Jul

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intuitive Surgical (ISRG), Quest Diagnostics (DGX) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
23 Jul

Ultragenyx Pharmaceutical Announces Inducement Grant of 45,292 Restricted Stock Units to New Employees

Reuters
·
19 Jul

THE APEX AIR-COOLED RUF OF THE NINETIES: BROAD ARROW ADDS EXCEEDINGLY RARE RUF CTR 2 SPORT TO MONTEREY JET CENTER AUCTION

GlobeNewswire
·
17 Jul

Ultragenyx Pharmaceutical: Buy Rating Affirmed Amid Manageable FDA Setbacks and Promising Clinical Data

TIPRANKS
·
15 Jul

Positive Outlook on Ultragenyx Pharmaceutical Despite Setback with UX111 Approval

TIPRANKS
·
14 Jul

Ultragenyx Pharma Is Maintained at Neutral by Wedbush

Dow Jones
·
14 Jul

Ultragenyx announces Health Canada extended approval of Evkeeza

TIPRANKS
·
14 Jul

Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)

GlobeNewswire
·
14 Jul

Morgan Stanley Cuts Price Target on Ultragenyx Pharmaceutical to $55 From $65, Keeps Overweight Rating

MT Newswires Live
·
14 Jul

Ultragenyx Receives FDA Complete Response Letter for UX111 Gene Therapy

MT Newswires Live
·
14 Jul

Ultragenyx falls 4% to $28.41 after FDA rejection letter for gene therapy

TIPRANKS
·
12 Jul

Ultragenyx trading resumes

TIPRANKS
·
12 Jul

Ultragenyx Says Metabolic Disorder Treatment Approval Likely Delayed to 2026

Dow Jones
·
12 Jul

US FDA declines to approve Ultragenyx's gene therapy for rare genetic disorder

Reuters
·
12 Jul

Ultragenyx Receives FDA Complete Response Letter for UX111 AAV Gene Therapy, Aiming for 2026 Approval After Addressing CMC Observations

Reuters
·
12 Jul

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires Live
·
11 Jul

Top Midday Decliners

MT Newswires Live
·
11 Jul

Crude Oil Down Over 2%; Delta Air Lines Posts Upbeat Earnings

Benzinga
·
11 Jul

Ultragenyx Pharma Is Maintained at Overweight by Wells Fargo

Dow Jones
·
10 Jul